- Home
- Publications
- Publication Search
- Publication Details
Title
Epigenomics and ovarian carcinoma
Authors
Keywords
-
Journal
Biomarkers in Medicine
Volume 4, Issue 4, Pages 543-570
Publisher
Future Medicine Ltd
Online
2010-08-11
DOI
10.2217/bmm.10.72
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aberrant Transforming Growth Factor β1 Signaling and SMAD4 Nuclear Translocation Confer Epigenetic Repression of ADAM19 in Ovarian Cancer
- (2015) Michael W.Y. Chan et al. NEOPLASIA
- Aberrant Promoter Methylation of Sparc in Ovarian Cancer
- (2015) Matthew J. Socha et al. NEOPLASIA
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
- (2010) Houtan Noushmehr et al. CANCER CELL
- Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
- (2010) Jiahuai Tan et al. Journal of Hematology & Oncology
- Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo
- (2009) N Steele et al. BRITISH JOURNAL OF CANCER
- Solving the Dnmt2 enigma
- (2009) Matthias Schaefer et al. CHROMOSOMA
- The promises and pitfalls of epigenetic therapies in solid tumours
- (2009) Janet S. Graham et al. EUROPEAN JOURNAL OF CANCER
- MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy
- (2009) Todd Boren et al. GYNECOLOGIC ONCOLOGY
- DNA methylation analysis in liquid-based cytology for cervical cancer screening
- (2009) Sophia Apostolidou et al. INTERNATIONAL JOURNAL OF CANCER
- The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?
- (2008) Vladimir Nossov et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia
- (2008) G. Garcia-Manero et al. BLOOD
- Imprinted tumor suppressor genesARHI andPEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation
- (2008) Weiwei Feng et al. CANCER
- Genome-Wide Promoter Analysis Uncovers Portions of the Cancer Methylome
- (2008) M. O. Hoque et al. CANCER RESEARCH
- Frequent Inactivation of a Putative Tumor Suppressor, Angiopoietin-Like Protein 2, in Ovarian Cancer
- (2008) R. Kikuchi et al. CANCER RESEARCH
- MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
- (2008) N. Yang et al. CANCER RESEARCH
- MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN
- (2008) H. Yang et al. CANCER RESEARCH
- Promoter Hypermethylation of the PALB2 Susceptibility Gene in Inherited and Sporadic Breast and Ovarian Cancer
- (2008) A. Potapova et al. CANCER RESEARCH
- Methyl-CpG binding proteins: specialized transcriptional repressors or structural components of chromatin?
- (2008) T. Clouaire et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- A Phase 1 Pharmacokinetic and Pharmacodynamic Study of the Histone Deacetylase Inhibitor Belinostat in Patients with Advanced Solid Tumors
- (2008) N. L. Steele et al. CLINICAL CANCER RESEARCH
- Tolerability, Pharmacodynamics, and Pharmacokinetics Studies of Depsipeptide (Romidepsin) in Patients with Acute Myelogenous Leukemia or Advanced Myelodysplastic Syndromes
- (2008) V. M. Klimek et al. CLINICAL CANCER RESEARCH
- Non-Invasive Tests in Animal Models and Humans: A New Paradigm for Assessing Efficacy of Biologics Including Prebiotics and Probiotics
- (2008) R. Butler CURRENT PHARMACEUTICAL DESIGN
- DNA methylation changes in ovarian cancer: Implications for early diagnosis, prognosis and treatment
- (2008) Caroline A. Barton et al. GYNECOLOGIC ONCOLOGY
- A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study
- (2008) Susan C. Modesitt et al. GYNECOLOGIC ONCOLOGY
- Epi-drugs to fight cancer: From chemistry to cancer treatment, the road ahead
- (2008) Antonello Mai et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- HOXA11 DNA methylation-A novel prognostic biomarker in ovarian cancer
- (2008) Heidi Fiegl et al. INTERNATIONAL JOURNAL OF CANCER
- An epigenetic marker panel for screening and prognostic prediction of ovarian cancer
- (2008) Her-Young Su et al. INTERNATIONAL JOURNAL OF CANCER
- Erratum: A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases
- (2008) Roberta Benetti et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells
- (2008) Lasse Sinkkonen et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer
- (2008) L. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The methylome: approaches for global DNA methylation profiling
- (2008) Stephan Beck et al. TRENDS IN GENETICS
- Tissue Inhibitor of Metalloproteinases-3 Promoter Methylation is an Independent Prognostic Factor for Bladder Cancer
- (2007) Mohammad Obaidul Hoque et al. JOURNAL OF UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now